Heinrich Biehl
About
Heinrich Biehl is from Copenhagen, Capital Region, Denmark. Heinrich works in the following industries: "Biotechnology". Heinrich is currently Member of the board at Euroclone SpA, located in Milano-området, Italien. Heinrich also works as Group CEO for the BioNordka Group, AddLife at AddLife AB, a job Heinrich has held since Mar 2018. Another title Heinrich currently holds is Chairman Of The Board at BioNordika Group. In Heinrich's previous role as a Member of the Board of Directors at Holm & Halby, BioNordika Sweden, BioNordika Norway, BioNordika Finland, Heinrich worked in until Mar 2018. Prior to joining Holm & Halby, BioNordika Sweden, BioNordika Norway, BioNordika Finland, Heinrich was a Country Manager/Nordic Sales & Marketing Manager at BioNordika Denmark / BioNordika Group and held the position of Country Manager/Nordic Sales & Marketing Manager at Glostrup, Denmark. Prior to that, Heinrich was a General Manager at BioNordika Denmark A/S, based in Glostrup, Denmark from Dec 2009 to Sep 2010. Heinrich started working as CEO at Jurag Separation A/S in Nov 2005. From Oct 2002 to Feb 2005, Heinrich was CSO at ORIGIO. Prior to that, Heinrich was a CEO at Amdex A/S from Sep 1998 to Oct 2002. Heinrich started working as Director of Sales & Marketing at ORIGIO in Aug 1997.
Heinrich Biehl's email is available on Finalscout.com free of charge. This database has a wealth of information on over half a billion business professionals and two hundred million companies.
Heinrich Biehl's current jobs
Overall responsibility for the BioNordika Group as well as its Danish subsidiary - BioNordika Denmark. Part of AddLife AB and member of its Labtech business unit.
Heinrich Biehl's past jobs
P&L responsible, development of and implementation of business strategies, Nordic business development, key account management, supplier contact and negotiation
Sales and marketing of high quality products within the life science segment with focus on cell biology, molecular biology, hematology, instruments and accessories from suppliers in Europa and USA. The company was established in 1986 and is part of the Nordic BioNordika Group. P&L responsible, development of and implementation of business strategies, Nordic business development, key account management, supplier contact and negotiation.
Danish start-up from 2001 specialising in developing, designing and delivering electro-membrane separation processes for the bio-pharmaceutical- and biotech fermentation industries as well as food and feed ingredient industries. Global responsibilities for continued development of the company as well as special focus on business development.
Origio (formerly MediCult) is a Danish, Norwegian biotechnology company with subsidiaries in all major countries that develops, produces and markets products and systems within infertility management and biopharmaceuticals. EVP of R&D with global responsibilities for research and development as well as general business development. Managing Director of the subsidiary Amdex A/S and member of the management team and Board of Directors
Danish diagnostic company with patented technology for signal amplification. Developing, producing and licensing its technology for incorporation by the diagnostic industry. Amdex was a subsidiary of MediCult A/S. Managing Director with reference to the Amdex board. Continued as VP Sales & Marketing executive of MediCult A/S and member of Board of Directors. Sold Amdex sold to an American diagnostic company in 2003.
Global responsibility of international sales- and marketing of business-to-business sales of cell culture media for the biotechnology and biopharmaceutical industry.
OEM BD in Europe/Japan
European sales & marketing responsibility. BD input to USA.